Long-term Anastrozole versus Tamoxifen Treatment Effects in breast cancer: an epidemiologial observational study

Trial Profile

Long-term Anastrozole versus Tamoxifen Treatment Effects in breast cancer: an epidemiologial observational study

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Anastrozole (Primary) ; Tamoxifen
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms LATTE
  • Most Recent Events

    • 01 Jun 2017 Status changed from recruiting to completed.
    • 10 Apr 2017 Planned End Date changed from 1 Oct 2015 to 21 Jan 2019.
    • 04 Dec 2015 Accrual to date is 29% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top